The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
Abstract
Evidence suggests that both motor and nonmotor symptoms contribute to health status in Parkinson's disease. Less clear is how much change in health status can be expected if these clinical variables change. In addition, anxiety, separate from depression, has rarely been examined as a predictor of health status. We used hierarchical multiple regression analysis and standardized beta coefficients in a prevalent cohort of 462 patients with Parkinson's disease to explore the relative impact on health status (measured using the Parkinson's Disease Questionnaire) of 5 well‐recognized symptom domains in Parkinson's disease: motor signs, depression, anxiety, cognition, and other nonmotor symptoms. In the health status scores, 19.6% of variance was explained by age, number of comorbidities, disease duration, and levodopa equivalent dose. Younger age predicted worse health status. A full regression model containing baseline variables and all 5 symptom domains explained 56% of the variance in health status. The standardized beta coefficient for depression was 2.1, 1.6, and 1.3 times that of motor signs, anxiety, and other nonmotor symptoms, respectively. Our findings provide a ranking order of clinical variables for their relative impact on health status in Parkinson's disease and show that depression has more than twice the impact of motor signs on health status. Anxiety and other nonmotor symptoms are also important separate determinants of poor health status in Parkinson's disease. Our results will help to guide the development of individual care and service planning for patients with Parkinson's disease. © 2011 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The non-motor symptoms of Parkinson’s disease (PD) can be as disabling for an individual as their motor symptoms, if not more so [1].”
From Distant delivery of a mindfulness-based intervention for people with Parkinson's disease: The study protocol of a randomised pilot trial (2017) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Discovering Statistics Using SPSS
Field, A. P., & Miles, J. N. V. (2000) · Medical Entomology and Zoology · Cited by 28,269
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · cited 1×
“Stage of disease was determined using the Hoehn and Yahr scale (H&Y).(14) Number of comorbid physical conditions was assessed using the Physical Health measure from the Duke Older Americans Resources and Services assessment.”
MethodMioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1610 · Cited by 2,016
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
What contributes to quality of life in patients with Parkinson's disease?
Schrag, A. E. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.308 · Cited by 1,420
Chaudhuri, К. R., Martínez‐Martín, P., Brown, R. G., Sethi, K. D., Stocchi, F., Odin, P., Ondo, W. G., Abe, K., Macphee, G. J. A., MacMahon, D., et al. (2007) · Movement Disorders · doi:10.1002/mds.21596 · Cited by 1,090
Self-citationFillenbaum, G. G. (1988) · Medical Entomology and Zoology · Cited by 769
Irreversible motor impairment in young addicts ? ephedrone, manganism or both?
Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Zjablov, G., Asser, T., & Aquilonius, S. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00818.x · Cited by 664
Puhan, M. A., Frey, M., Büchi, S., & Schünemann, H. J. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-46 · Cited by 586
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–141 of 141
Caregivers’ Burden in Parkinson’s Disease: A Study on Related Features and Attachment Styles
Carpinelli, L., Savarese, G., Russo, C., Stornaiuolo, G., Luisi, E., Pellegrino, F., Mollo, M., & Pellecchia, M. T. (2023) · Human Arenas · doi:10.1007/s42087-023-00350-w · Cited by 5
Galeoto, G., Berardi, A., Simeon, R., Panuccio, F., Fabbrini, G., Belvisi, D., Gonzalez-Bernal, J. J., & Seco‐Calvo, J. (2024) · Healthcare · doi:10.3390/healthcare12131351 · Cited by 4
Prevalence, impact, and management of depression and anxiety in patients with Parkinson’s disease
Renfroe, J. B., Turner, T. H., & Hinson, V. K. (2016) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s83165 · Cited by 5
Ou, R., Hou, Y., Song, W., Wei, Q., Chen, Y., Cao, B., Yuan, X., & Shang, H. (2018) · Neurological Research · doi:10.1080/01616412.2018.1438227 · Cited by 4
Development and validation of quality of life in Parkinson's disease instrument
Behari, M., Aggarwal, R., Goyal, V., Pandey, R., Kumar, N. K., Singh, S., & Shukla, G. (2019) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_471_18 · Cited by 4
Chan, L. M. L., Lee, J. J., Lam, W., Chan, K. H., Pang, S., & Kwok, J. Y. Y. (2025) · Palliative Medicine · doi:10.1177/02692163251394908 · Cited by 3
Recent Developments in the Drug Treatment of Parkinson’s Disease
Leiter, S., Mahlknecht, P., & Poewe, W. H. (2026) · Drugs · doi:10.1007/s40265-026-02327-9 · Cited by 3
Defining the unknowns for cell therapies in Parkinson's disease
Lane, E. L., & Lelos, M. J. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049543 · Cited by 4
THE VALIDITY AND RELIABILITY OF THE TURKISH FORM OF THE SCOPA SLEEP SCALE IN PARKINSON’S DISEASE
Kongur, N. S., Tosun, Z., Özkan, S., Turgut, N., & Ünal, A. (2020) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27466 · Cited by 3
Barreto, K. S., Filho, J. O., Reis, L. D., Ribeiro, T. G., & Kauark, R. B. G. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2021-0056 · Cited by 3
Aldeen, H. S., Houlden, H., & Rizig, M. (2024) · Clinical Medicine · doi:10.1016/j.clinme.2024.100177 · Cited by 2
Pharmacological treatment of palliative care patients with Parkinson’s disease
Żylicz, Z. (2022) · Palliative Medicine in Practice · doi:10.5603/pmpi.2022.0007 · Cited by 2
Can cell and gene therapies improve cognitive symptoms in Parkinson’s disease?
Lelos, M. J. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2103078 · Cited by 2
Rodríguez-Antigüedad, J., Bojtos, L., & Kulisevsky, J. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03142-y · Cited by 1
Barboza, N. M. (2014) · Journal of Yoga & Physical Therapy · doi:10.4172/2157-7595.1000170 · Cited by 1
Mann, S., Miller, R. B., Hill, L. M. S., & Dobkin, R. (2020) · Pragmatic Case Studies in Psychotherapy · doi:10.14713/pcsp.v16i1.2069 · Cited by 1
Chamaa, F., Darwish, B., Saadé, N. E., & Abou-Kheir, W. G. (2020) · Neuromethods · doi:10.1007/978-1-0716-1146-3_4 · Cited by 1
Fereshtehnejad, S. (2015) · Figshare · Cited by 1
Semiclassical 3-point function in WZWAdS3model
Bozhilov, P., Furlan, P., Petkova, V. B., & Stanishkov, M. (2013) · Journal of Physics Conference Series · doi:10.1088/1742-6596/411/1/012008
La dysrégulation hédoniste comme forme d’anosognosie dans la maladie de Parkinson ?
Bruneau, M. (2016) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2016.03.007
Treatment of depression and anxiety in Parkinson’s Disease
Troeung, L. (2013) · eSpace (Curtin University)
Barber, C. L. (2016) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2016.12.5.235
Understanding the influence of anxiety on gait in Parkinson's disease
Martens, E., & Kaylena, A. (2015) · UWSpace (University of Waterloo)
Ensemble Statistical Modelling of Risk Factors in Health
Thomas, A. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.120675
Hippocampal Neurogenesis in Neurodegenerative Movement Disorders
Kohl, Z., Winner, B., & Winkler, J. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-1908-6_5
(2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328359edae
THE NEGATIVE EFFECT OF PARKINSON'S DISEASE ON THE PATIENT'S PSYCHOLOGICAL AND SOCIAL WELL-BEING
Lauková, J., Šupínová, M., Frčová, Z., Janiczeková, E., Ivaničová, D., & Jankovičová, J. (2022) · Ošetřovatelské perspektivy · doi:10.25142/osp.2022.009
Sexu-desberdintasunak Parkinson gaixotasunean
Zubelzu, M., Leivar, A., Morera‐Herreras, T., & Murueta‐Goyena, A. (2023) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.23974
da Silva, K. G. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-18042023-144145
State-dependent alteration of respiration in a rat model of Parkinson diseasePreprint
Walker, J., Meunier, E., Garcia, S., Messaoudi, B., Mouly, A., Veyrac, A., Buonviso, N., & Courtiol, E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.10.566528
MỘT SỐ TRIỆU CHỨNG NGOÀI VẬN ĐỘNG Ở NGƯỜI BỆNH PARKINSON GIAI ĐOẠN TRUNG BÌNH VÀ NẶNG
Nguyễn, T. B. L., & Nguyễn, V. L. (2024) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v533i1.7733
Perceptions of people with Parkinson’s on non-motor symptoms and functional ability
Leung, C., Hale, L. A., Swain, N., & Jayakaran, P. (2024) · New Zealand Journal of Physiotherapy · doi:10.15619/nzjp.v52i2.360
Factors related to non-motor symptoms in moderate to severe parkinson’s disease
Nguyen, T. B. L., Nguyen, V. L., & Ho, T. T. (2025) · Tạp chí thần kinh học Việt Nam · doi:10.62511/vjn.44.2025.050
Mendorf, S., Heimrich, K. G., Mühlhammer, H. M., Schönenberg, A., & Prell, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322089
Metta, V., Kandadai, R. M., Hosurkar, G., Wadia, P. M., Sankhla, C. S., Agarwal, P. A., Gurram, S., Garg, D., Mehta, S., Kumar, H., et al. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03106-2
Hunsdon, R., & Ho, A. K. (2026) · Aging & Mental Health · doi:10.1080/13607863.2026.2648693
Matos‐Pina, I., Moura‐Ramos, M., & Ferreira, C. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2723528
Metadata
- Authors
- Hinnell, C., Hurt, C. S., Landau, S., Brown, R. G., Samuel, M., & on behalf of the PROMS‐PD Study Group
- Affiliations
- Kings Health Partners (GB)
- King's College London (GB)
- William Harvey Hospital (GB)
- Corresponding author
- Samuel, Michael
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2011-09-27
- Volume
- 27
- Issue
- 2
- Pages
- 236-241
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2029474945
- Cited by
- 142
- References
- 42
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 13 · 2021: 8 · 2020: 12 · 2019: 9 · 2018: 10 · 2017: 8 · 2016: 12 · 2015: 10 · 2014: 14 · 2013: 11 · 2012: 7
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- City Research Online (City University London) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Parkinson's UK (J-0601)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, health status, non-motor symptoms, motor symptoms, depression, anxiety, cognition, Parkinson's Disease Questionnaire, levodopa equivalent daily dose, comorbidities, disease duration
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Anxiety, Depression, Disability Evaluation, Female, Health Status, Humans, Male, Middle Aged, Parkinson Disease, Quality of Life, Surveys and Questionnaires, Regression Analysis, Severity of Illness Index, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review